|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
"""Telestroke"" : the application of telemedicine for stroke."
|
9933289 |
1999 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Tissue plasminogen activator for acute ischemic stroke.
|
7477192 |
1995 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
|
17903947 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
tPA-associated reperfusion after acute stroke demonstrated by SPECT.
|
9472885 |
1998 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
|
17903870 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
9259745 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment.
|
9056608 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
|
12221155 |
2002 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
"""Telestroke"" : the application of telemedicine for stroke."
|
9933289 |
1999 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
A method to determine stroke trial success using multidimensional pooled control functions.
|
19286598 |
2009 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Patients received alteplase up to 9 hours after the onset or on awakening based on automated perfusion imaging. sICH was ascertained using ECASS II (The Second European-Australasian Acute Stroke Study) criteria.
|
31394994 |
2019 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
|
20536612 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Nursing management of acute complications following rt-PA in acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
|
9479658 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group.
|
2124386 |
1990 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
|
12221155 |
2002 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.
|
9479657 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
|
10171637 |
1993 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group.
|
2124386 |
1990 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
|
15087567 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Combined X-ray angiography and diffusion-perfusion MRI for studying stroke evolution after rt-PA treatment in rats.
|
12384244 |
2002 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.
|
18560214 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
|
2514002 |
1989 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
|
16809570 |
2006 |